GeparX: Denosumab (Dmab) as add-on to different regimen of nab-paclitaxel (nP)-anthracycline based neoadjuvant chemotherapy (NACT) in early breast cancer (BC): Subgroup analyses by RANK expression and HR status - Link, T.; Blohmer, J-U.; Just, M.; Untch, M.; Stoetzer, O.; Fasching, Peter; Schneeweiss, A.; Wimberger, P.; Seiler, S.; Huober, J.; Schmitt, W. D.; Jackisch, C.; et al. (ANNALS OF ONCOLOGY, 2020)
CRIS-Team WoS Importer:2020-10-30